Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer's stock has been struggling post-COVID-19 due to challenges like patent cliffs and regulatory shakeups. Despite a low valuation and high dividend yield, uncertainties make holding Pfizer stock challenging.